Pfizer raises 2021 Covid-19 vaccine sales forecast to $33.5 billion
Pfizer gained a head start in December with the first US emergency authorization of a Covid-19 vaccine, and has since jumped ahead of rivals that have faced manufacturing hurdles
সম্পূর্ণ আর্টিকেলটি পড়ুন
We use cookies to ensure you get the best experience on our website.